Moderna announced Monday that it has begun an underwritten public offering of $1.25 billion in shares of common stock.
at least $1.25 billion in fresh stock after releasing the results of its phase 1 trial, the company said Monday.on its early-stage human trial for a Covid-19 vaccine earlier Monday. The closely watched vaccine trial produced Covid-19 antibodies in all 45 participants, sending the company's shares surging nearly 20%.
Moderna said it expects to primarily use the proceeds to fund the manufacturing and distribution of its vaccine candidate, mRNA-1273 once it's approved by federal regulators. Morgan Stanley is the running the deal. Moderna is giving the underwriters a 30-day option to buy up to an additional $187.5 million in common stock.
If there are any remaining proceeds, the company hopes "to fund clinical development and drug discovery in existing and new therapeutic areas; to fund further development of its mRNA technology platform and the creation of new modalities; or to fund working capital and other general corporate purposes."
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Stripe picks $1 million in carbon-removal projects to spur industryInstead of buying cheap carbon offsets, online-payment company Stripe founders are importing special sand to a remote Caribbean beach so waves can grind up coarse-milled olivine, allowing the ocean to absorb more carbon
Weiterlesen »
Oil prices climb more than $1 ahead of WTI June contract expiryOil prices jumped by more than $1 a barrel on Monday to their highest in more than a month, supported by ongoing output cuts and signs of gradual recovery in fuel demand as more countries ease curbs imposed to stop the coronavirus pandemic spreading.
Weiterlesen »
Moderna plans to sell more than $1 billion in fresh stock after COVID-19 vaccine study successAfter announcing positive results of a study of its potential COVID-19 vaccine and seeing shares jump 20% to record highs Monday, Moderna Inc. undefined...
Weiterlesen »
Moderna plans to sell more than $1 billion in fresh stock after COVID-19 vaccine study successAfter announcing positive results of a study of its potential COVID-19 vaccine and seeing shares jump 20% to record highs Monday, Moderna Inc. undefined...
Weiterlesen »
Stocks rebound as positive Moderna vaccine trial boosts optimism for economic recoveryStocks bounced back Monday on optimism the U.S. economy may start to recover from the coronavirus pandemic after drugmaker Moderna released promising early results for a vaccine.
Weiterlesen »